Atovaquone Patent Expiration

Atovaquone is Used for treating Pneumocystis carinii infections. It was first introduced by Glaxosmithkline Llc in its drug Mepron on Nov 25, 1992. 10 different companies have introduced drugs containing Atovaquone.


Atovaquone Patents

Given below is the list of patents protecting Atovaquone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Mepron US6649659

(Pediatric)

Atovaquone pharmaceutical compositions Jan 10, 2017

(Expired)

Glaxosmithkline Llc
Mepron US6649659 Atovaquone pharmaceutical compositions Jul 10, 2016

(Expired)

Glaxosmithkline Llc



Atovaquone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Atovaquone Generic API Manufacturers

Several generic applications have been filed for Atovaquone. The first generic version for Atovaquone was by Amneal Pharmaceuticals and was approved on Mar 18, 2014. And the latest generic version is by Abon Pharmaceuticals Llc and was approved on Oct 25, 2021.

Given below is the list of companies who have filed for Atovaquone generic, along with the locations of their manufacturing plants worldwide.


1. ABHAI LLC

Abhai Llc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Abhai Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB May 31, 2019





2. ABON PHARMS LLC

Abon Pharmaceuticals Llc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Abon Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Oct 25, 2021





3. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Mar 18, 2014





4. APOTEX

Apotex Inc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Oct 11, 2017


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Etobicoke Apotex, Inc.
Brantford Apotex Pharmachem Inc.
Winnipeg Apotex Fermentation Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





5. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Mar 30, 2021


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Apr 28, 2017





7. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Nov 21, 2018





8. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Oct 11, 2018





9. LUPIN LTD

Lupin Ltd has filed for 1 generic for Atovaquone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
750MG/5ML

suspension Prescription ORAL AB Sep 11, 2018


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.